[Efficacy and safety of first-line treatment with anti-CD38 monoclonal antibody-based regimen for primary plasma cell leukemia].
Dou XL, Liu RX, Liu Y, Peng N, Wen L, Wu Y, Li Q, Zhong YP, Zhou X, Liao AJ, Jiang HN, Ma XJ, Dong HH, Fan SJ, Zhao YQ, Hu DH, Lu J.
Dou XL, et al.
Zhonghua Yi Xue Za Zhi. 2024 Feb 20;104(7):499-506. doi: 10.3760/cma.j.cn112137-20231005-00634.
Zhonghua Yi Xue Za Zhi. 2024.
PMID: 38317361
Chinese.